PHENOXYBENZAMINE HYDROCHLORIDE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Phenoxybenzamine Hydrochloride, and what generic alternatives are available?
Phenoxybenzamine Hydrochloride is a drug marketed by Amneal, Aurobindo Pharma, Endo Operations, Hikma, Novitium Pharma, and Rising. and is included in six NDAs.
The generic ingredient in PHENOXYBENZAMINE HYDROCHLORIDE is phenoxybenzamine hydrochloride. There are seven drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the phenoxybenzamine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Phenoxybenzamine Hydrochloride
A generic version of PHENOXYBENZAMINE HYDROCHLORIDE was approved as phenoxybenzamine hydrochloride by ENDO OPERATIONS on January 24th, 2017.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for PHENOXYBENZAMINE HYDROCHLORIDE?
- What are the global sales for PHENOXYBENZAMINE HYDROCHLORIDE?
- What is Average Wholesale Price for PHENOXYBENZAMINE HYDROCHLORIDE?
Summary for PHENOXYBENZAMINE HYDROCHLORIDE
US Patents: | 0 |
Applicants: | 6 |
NDAs: | 6 |
Finished Product Suppliers / Packagers: | 5 |
Raw Ingredient (Bulk) Api Vendors: | 104 |
Clinical Trials: | 7 |
Patent Applications: | 637 |
What excipients (inactive ingredients) are in PHENOXYBENZAMINE HYDROCHLORIDE? | PHENOXYBENZAMINE HYDROCHLORIDE excipients list |
DailyMed Link: | PHENOXYBENZAMINE HYDROCHLORIDE at DailyMed |
Recent Clinical Trials for PHENOXYBENZAMINE HYDROCHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Seoul National University Hospital | Phase 4 |
University of California, Los Angeles | Phase 3 |
Leiden University Medical Center | Phase 4 |
Pharmacology for PHENOXYBENZAMINE HYDROCHLORIDE
Drug Class | alpha-Adrenergic Blocker |
Mechanism of Action | Adrenergic alpha-Antagonists |